160 related articles for article (PubMed ID: 33368684)
21. Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling.
Marchianò S; Biagioli M; Roselli R; Zampella A; Di Giorgio C; Bordoni M; Bellini R; Urbani G; Morretta E; Monti MC; Distrutti E; Fiorucci S
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Nov; 1867(11):159218. PubMed ID: 35985473
[TBL] [Abstract][Full Text] [Related]
22. Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling.
Cipriani S; Renga B; D'Amore C; Simonetti M; De Tursi AA; Carino A; Monti MC; Sepe V; Zampella A; Fiorucci S
PLoS One; 2015; 10(7):e0129866. PubMed ID: 26177448
[TBL] [Abstract][Full Text] [Related]
23. Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand.
Carino A; Biagioli M; Marchianò S; Scarpelli P; Zampella A; Limongelli V; Fiorucci S
Pharmacol Res; 2018 May; 131():17-31. PubMed ID: 29530598
[TBL] [Abstract][Full Text] [Related]
24. BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis.
Carino A; Cipriani S; Marchianò S; Biagioli M; Santorelli C; Donini A; Zampella A; Monti MC; Fiorucci S
Sci Rep; 2017 Feb; 7():42801. PubMed ID: 28202906
[TBL] [Abstract][Full Text] [Related]
25. GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis.
Biagioli M; Carino A; Fiorucci C; Marchianò S; Di Giorgio C; Roselli R; Magro M; Distrutti E; Bereshchenko O; Scarpelli P; Zampella A; Fiorucci S
Cell Mol Gastroenterol Hepatol; 2019; 8(3):447-473. PubMed ID: 31226434
[TBL] [Abstract][Full Text] [Related]
26. The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity.
Biagioli M; Carino A; Fiorucci C; Marchianò S; Di Giorgio C; Bordoni M; Roselli R; Baldoni M; Distrutti E; Zampella A; Fiorucci S
J Immunol; 2020 May; 204(9):2535-2551. PubMed ID: 32213564
[TBL] [Abstract][Full Text] [Related]
27. Insights on FXR selective modulation. Speculation on bile acid chemical space in the discovery of potent and selective agonists.
Sepe V; Festa C; Renga B; Carino A; Cipriani S; Finamore C; Masullo D; Del Gaudio F; Monti MC; Fiorucci S; Zampella A
Sci Rep; 2016 Jan; 6():19008. PubMed ID: 26740187
[TBL] [Abstract][Full Text] [Related]
28. Bile acids and their receptors in metabolic disorders.
Fiorucci S; Distrutti E; Carino A; Zampella A; Biagioli M
Prog Lipid Res; 2021 Apr; 82():101094. PubMed ID: 33636214
[TBL] [Abstract][Full Text] [Related]
29. Identification of an Oleanane-Type Triterpene Hedragonic Acid as a Novel Farnesoid X Receptor Ligand with Liver Protective Effects and Anti-inflammatory Activity.
Lu Y; Zheng W; Lin S; Guo F; Zhu Y; Wei Y; Liu X; Jin S; Jin L; Li Y
Mol Pharmacol; 2018 Feb; 93(2):63-72. PubMed ID: 29162643
[TBL] [Abstract][Full Text] [Related]
30. Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity.
Manley S; Ni HM; Williams JA; Kong B; DiTacchio L; Guo G; Ding WX
Redox Biol; 2014; 2():991-1002. PubMed ID: 25460735
[TBL] [Abstract][Full Text] [Related]
31. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
[TBL] [Abstract][Full Text] [Related]
32. Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injury.
Biagioli M; Marchianò S; di Giorgio C; Roselli R; Bordoni M; Bellini R; Fiorillo B; Sepe V; Catalanotti B; Cassiano C; Monti MC; Distrutti E; Zampella A; Fiorucci S
Hepatology; 2023 Jul; 78(1):26-44. PubMed ID: 36107019
[TBL] [Abstract][Full Text] [Related]
33. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
34. A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice.
Wang XX; Luo Y; Wang D; Adorini L; Pruzanski M; Dobrinskikh E; Levi M
J Biol Chem; 2017 Jul; 292(29):12018-12024. PubMed ID: 28596381
[TBL] [Abstract][Full Text] [Related]
35. The hepatic orosomucoid/α1-acid glycoprotein gene cluster is regulated by the nuclear bile acid receptor FXR.
Porez G; Gross B; Prawitt J; Gheeraert C; Berrabah W; Alexandre J; Staels B; Lefebvre P
Endocrinology; 2013 Oct; 154(10):3690-701. PubMed ID: 23861371
[TBL] [Abstract][Full Text] [Related]
36. Immunomodulatory functions of FXR.
Fiorucci S; Zampella A; Ricci P; Distrutti E; Biagioli M
Mol Cell Endocrinol; 2022 Jul; 551():111650. PubMed ID: 35472625
[TBL] [Abstract][Full Text] [Related]
37. Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR.
Jadhav K; Xu Y; Xu Y; Li Y; Xu J; Zhu Y; Adorini L; Lee YK; Kasumov T; Yin L; Zhang Y
Mol Metab; 2018 Mar; 9():131-140. PubMed ID: 29361497
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.
Kim I; Ahn SH; Inagaki T; Choi M; Ito S; Guo GL; Kliewer SA; Gonzalez FJ
J Lipid Res; 2007 Dec; 48(12):2664-72. PubMed ID: 17720959
[TBL] [Abstract][Full Text] [Related]
39. Structural Insight into the Binding Mode of FXR and GPBAR1 Modulators.
Di Leva FS; Di Marino D; Limongelli V
Handb Exp Pharmacol; 2019; 256():111-136. PubMed ID: 31161298
[TBL] [Abstract][Full Text] [Related]
40. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
